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Abstract 
 
 
Introduction: One of the challenges that the forensic community faces is how to 
find a reliable biomarker and turning it into an accurate tool for a rapid identification of 
body fluids. Driven by their important forensic applications, body fluid identification 
methods have been extensively developed in recent years. Two of the most common 
types of body fluids found in forensic scenes are blood and urine; however, most of the 
current techniques used to identify these fluids aren’t very accurate and have a low 
sensitivity that often lead to false positive results. Consequently, finding an accurate 
identification tool for these fluids would be particularly useful. Recently, it was found that 
the intrinsically short fragment and tissue-specific expression of microRNAs (miRNAs) 
make them ideal biomarkers for forensic body fluid identification. MiRNAs are small 
endogenous, 19 to 24 nucleotides in length, single-stranded, non-protein coding 
regulatory RNA molecules that modulate cellular mRNA and protein levels by inhibiting 
protein translation or destabilizing target transcripts. To date, no miRNA was detected as 
a biomarker for blood or urine identification. Therefore, the main objective of the present 
study is to identify a specific miRNA profile useful for plasma and urine sample’s 
identification. 
Material and Methods: Following a review of the literature, we selected the miR-
801, miR-369-3p and miR-323b-5p to be evaluated as forensic biomarkers. The miRNA 
expression profiling study was conducted in plasma and urine samples from twenty-two 
healthy individuals (age 46.6 ± 17.78 years) using relative quantification by real-time PCR. 
Results: All the miRNAs tested were detected in both fluids, with different detection 
frequencies. We observed that miR-369-3p presented higher expression levels in plasma 
when compared to urine samples (fold-change: 37.52; P< 0.001). However, there were no 
statistically significant differences in the expression levels of miR-323b-5p and miR-801 
between plasma and urine samples. No significant statistical difference was detected, for 
either fluid, in the levels of the miR-801 and miR-323b-5p according to gender or age. 
MiR-369-3p also exhibited no significant statistical difference in expression levels between 
the male and female samples; however, it was the only miRNA with a significant statistical 
difference between the two age groups tested, as the older group (≥ 48 years) presented 
a higher miR-369-3p relative expression than the younger individuals (Urine: P=0.018; 
Plasma: P=0.037).  
Discussion: The up-regulation of miR-369-3p observed in older individuals (in 
plasma and urine) could influence UQCRFS1 regulation and consequently, influence the 
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aging process. Nonetheless, since miR-369-3p was only detected in two urine samples 
from male individuals versus fourteen urine samples from women, it could indicate that 
this miRNA may play a more relevant role in women; thus, we also suggest that the 
hormonal changes caused by menopause could explain the statistical difference between 
the two age groups in urine samples. Moreover, this was the first time that miR-801 was 
detected in plasma samples, and miR-323b-5p in urine samples; hence, we suggest 
further studies with a larger number of samples to replicate these results. 
Conclusion: We can hypothesize that miR-369-3p could be a potential molecular 
biomarker, allowing the distinction of two of the most frequently found body fluids in 
forensic scenarios. Nevertheless, we suggest more studies to be carried out, with a higher 
number of samples, in order to replicate these results. This miRNA also shows potential 
as an age biomarker; although, we propose future studies to be performed, using 
individuals with larger age ranges and gender heterogeneity to test this hypothesis. 
MiRNA detection in body fluids is an emerging field in the world of biomarkers that could 
represent a novel approach to the identification of forensically relevant biological stains. 
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Sinopse 
 
 
Introdução: Um dos maiores desafios que a comunidade forense enfrenta é 
encontrar um biomarcador fiável e transformá-lo numa ferramenta útil na identificação 
rápida de fluidos corporais. Devido à importância das suas aplicações forenses, os 
métodos de identificação de fluidos corporais têm sido bastante desenvolvidos nos 
últimos anos; porém, a maioria dos métodos de identificação usados atualmente 
apresentam uma baixa especificidade e sensibilidade, o que pode conduzir a resultados 
falsos-positivos. Um dos tipos de fluidos biológicos mais frequentemente encontrados em 
cenas de crime, em especial em cenas de crimes violentos, é o sangue. A maioria das 
técnicas atuais para a identificação de sangue recorrem a biomarcadores de proteínas 
que podem ter modificações ao nível da pós-tradução, afetando assim a precisão da 
identificação. A urina, frequentemente encontrada em casos de agressão sexual, assédio 
e má conduta, é um fluido biológico bastante difícil de detetar devido à baixa 
sensibilidade dos testes disponíveis, que podem levar a resultados falsos positivos. Deste 
modo, existe a necessidade de se encontrar um teste de confirmação universal, que 
possa ser aplicado a uma mancha ou fluido desconhecido, sendo capaz de identificar 
corretamente a presença de sangue ou urina. Recentemente, verificou-se que o curto 
tamanho e expressão específica nos tecidos dos microRNAs (miRNAs) torna-os 
biomarcadores ideais para a identificação de fluidos corporais com interesse forense. Os 
miRNAs pertencem a uma pequena classe de moléculas de RNA não codificante, com 19 
a 24 nucleótidos de tamanho, possuem cadeia simples e regulam a expressão génica por 
inibição da tradução ou destabilizando transcritos alvo, geralmente na região não 
traduzida 3’ (UTR), através de complementaridade parcial da sequência. Conhecer os 
padrões de expressão dos miRNAs em diferentes fluidos pode representar um novo 
método para a identificação de fluidos biológicos com relevância médico-legal e, tem 
ainda o potencial para ser particularmente útil na análise de amostras comprometidas ou 
degradadas, que são frequentemente encontradas em cenários forenses. Até à data, não 
foi detetado nenhum miRNA como biomarcador para a identificação de plasma e de 
urina, o que revela uma lacuna que a análise forense de perfis de miRNAs precisa de 
colmatar. Como tal, o principal objetivo do presente estudo é identificar um perfil de 
miRNAs útil para a identificação de amostras biológicas de plasma e urina. 
Material & Métodos: Uma revisão sistemática da literatura revelou três miRNAs 
que mostram o potencial para serem biomarcadores forenses: o miR-801 e o miR-369-3p 
(para análise em amostras de plasma) e o miR-323b-5p (para análise em amostras de 
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urina). O presente foi realizado a partir de amostras de plasma e urina provenientes de 
vinte e dois indivíduos adultos saudáveis da população portuguesa (46,6 ± 17,78 anos). 
Para quantificar a expressão de miRNAs, reações de PCR em tempo real foram 
realizadas. O tratamento estatístico dos resultados foi realizado usando o programa 
IBM®SPSS®Statistics (versão 22.0).  
Resultados: Todos os miRNAs testados foram detetados em ambos os fluidos, 
apresentando diferentes frequências de deteção. Observou-se que miR-369-3p 
apresentou maiores níveis de expressão no plasma quando comparado com amostras de 
urina (Fold-change= 37,52; P< 0,001). Não se verificaram diferenças estatisticamente 
significativas nos níveis de expressão do miR-323b-5p e do miR-801 entre as amostras 
de plasma e urina. Nenhuma diferença estatisticamente significativa foi detetada, em 
ambos os fluidos, quanto aos níveis do miR-801 e miR-323b-5p em relação à idade ou ao 
género. O mir-369-3p também não apresentou nenhuma diferença estatisticamente 
significativa entre as amostras masculinas e femininas; no entanto, foi o único miRNA a 
apresentar uma diferença estatisticamente significativa entre os dois grupos etários 
testados, uma vez que o grupo mais velho (≥ 48 anos) apresentou uma maior expressão 
relativa de miR-369-3p em relação aos indivíduos mais jovens (Urina: P=0,018; Plasma: 
P= 0,037). 
 Discussão: Os níveis elevados de miR-369-3p observados nos indivíduos mais 
velhos (no plasma e na urina) podem influenciar a regulação do gene UQCRFS1 e, 
consequentemente influenciar o processo de envelhecimento. No entanto, o miR-369-3p 
foi apenas detetado em duas amostras de urina de indivíduos do género masculino 
versus catorze amostras de urina de mulheres, o que poderá indicar que este miRNA 
desempenhará um papel mais relevante em mulheres. Deste modo, sugere-se que as 
alterações hormonais causadas pela menopausa poderão também explicar a diferença 
estatística entre as duas faixas etárias, nas amostras de urina. O presente estudo foi o 
primeiro a detetar o miR-801 em amostras de plasma e o miR-323b-5p em amostras de 
urina, pelo que se sugere a realização de novos estudos, com um número maior de 
amostras biológicas, para validar os presentes resultados. 
Conclusão: Coloca-se a hipótese que o miR-369-3p poderá ser um potencial 
biomarcador molecular, permitindo a distinção de dois dos fluidos biológicos mais 
frequentemente encontrados em cenários forenses. No entanto, propõe-se ainda que 
este estudo seja replicado com uma amostragem maior. Este miRNA também demonstra 
potencial como um biomarcador de idade. Porém, propomos que estudos futuros sejam 
executados, com uma maior heterogeneidade a nível de género e de idades para testar 
esta hipótese. A deteção de miRNAs em fluidos biológicos é um campo emergente no 
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mundo dos biomarcadores e pode representar uma nova abordagem para a identificação 
de manchas biológicas com interesse forense. 
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1. Introduction 
 
 
1.1. When DNA is not enough 
 
One of the challenges that the forensic community faces is how to find a reliable 
biomarker and turning it into an accurate tool for rapid identification of body fluids [1]. 
Driven by their important forensic applications, body fluid identification methods have 
been extensively developed in recent years [2]. 
For the past 30 years, advances in forensic deoxyribonucleic acid (DNA) technology 
have revolutionized the criminal justice system worldwide [3]. The demonstrated scientific 
accuracy of DNA testing for forensic purposes quickly led jurisdictions to accept expert 
testimony regarding DNA matches between suspects and crime scene evidence, in the 
late 1980s [3]. Wielding the power to exonerate the innocent and apprehend the guilty, the 
use of DNA genotyping technology has become an indispensable resource for 
prosecutors and law enforcement officials, as well as for defense lawyers representing 
those falsely accused, or wrongfully convicted of crimes they did not commit [3]. 
DNA profiling allows for the identification of individuals through their respective DNA 
signatures; nevertheless, it does not identify the type or source of the evidence [4]. What if 
there isn’t enough genetic material to obtain a complete DNA profile? Or what if the 
genetic material is degraded? Based on the theory that each type of body tissue has a 
distinctive ribonucleic acid (RNA) signature, messenger RNA (mRNA) profiling has 
appeared as an advantageous procedure to identify relevant human body fluids [4]. 
However, it is well know that despite the achievement of mRNA profiling, its susceptibility 
to degradation by physical or chemical factors has always been problematic [4]. Recently, 
it was found that the intrinsically short fragment and tissue-specific expression of 
microRNAs (miRNAs) make them ideal biomarkers for forensic body fluid identification [1, 
5]. 
In a breakthrough investigation Victor Ambros and his colleagues, Rosalind Lee and 
Rhonda Feinbaum, discovered that lin-4, a gene known to control the timing of 
Caenorhabditis elegans (C. elegans) larval development, does not code for a protein but 
produces a pair of small RNAs [6, 7].  
Since then, miRNAs have been shown to intervene in the regulation of several key 
cellular functions and have been implicated in many diseases [8]. Within the past few 
years, extracellular circulating miRNAs have been detected in a variety of biologic fluids 
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[4, 5, 8-13]. These miRNAs have many of the properties of an ideal biomarker, including 
stability in nuclease-rich body fluids, unique sequences, and tissue-specific expression [8]. 
MiRNA detection in body fluids is an emerging field in the world of biomarkers, and 
since more than 1800 transcribed miRNAs have been identified in the human genome, 
miRNAs could very well represent a novel approach to the identification of forensic 
biological stains, which may prove to be particularly useful in the analysis of compromised 
and degraded samples that are frequently encountered in forensic casework [10, 14, 15]. 
 
 
1.2. Body fluid stain identification in Forensic Sciences 
 
Body fluid samples found during a forensic investigation are amongst the most 
important evidences recovered from crime scenes, providing forensic pathologists and 
researchers with key information that allows the identification of victims and suspects, as 
well as to exonerate an innocent individual. Moreover, they are also excellent indicators of 
the sequence of events and can even help to corroborate testimonial evidences [1, 2, 4, 
16, 17]. 
Sometimes just knowing the origin of a fluid could be enough to influence the 
outcome of a case [18]. However, this is not always an easy task, as most body fluids’ 
physical appearance and molecular properties (e.g. DNA, mRNA) alter rapidly with time 
and environmental conditions, and many body fluid stains are either invisible to the naked 
eye or similar in appearance to other fluids or substances [2, 4]. Even when the identity of 
a stain may seem obvious to a forensic investigator, an absolute and accurate 
confirmation is necessary in order for that evidence to be accepted in court [2]. This is 
especially important in cases of a possible occurrence of mixtures from different body 
fluids. On the other hand, it is also important to take into account that a stain can contain 
multiple body fluids from more than one donor [2]. 
For more than a century, numerous types of body fluid identification methods have 
been developed; nevertheless, the most conventional serology-based methods for body 
fluid identification are prone to various limitations. Nowadays, several platforms are used 
for the detection and identification of biological traces, giving particular emphasis to 
presumptive and confirmatory tests [2, 4, 16]. When a potential body fluid is discovered at 
a crime scene, multiple presumptive tests are initially used, carried out in one body fluid at 
a time, to give some indication as to the identity of the substance, and then further 
confirmatory tests are conducted to confirm the presence of the fluid or identify the source 
of origin [10, 16]. As a result, these methods have an high cost, not only in terms of the 
1. Introduction 
 
 
Extracellular microRNAs in Forensic Sciences: potential biomarkers for body fluid identification 
29 
time and labor required for their completion, but also in terms of the amount of sample 
consumed during each test [10]. In general, presumptive and confirmatory tests also have 
a low specificity and sensitivity, and can lead to the destruction of the analyzed sample or 
to the instability of the biomolecules assessed [2, 16, 19].  
Due to the many limitations these tests display, in recent years, there have been 
great advances in the search for an accurate method for the rapid identification of body 
fluids [2, 16, 19]. The use of a molecular genetics-based approach, using the detection of 
specific miRNA profiles in body fluids, has been proposed in order to supplant 
conventional body fluid identification methods, and has shown promising results. These 
results are extremely important for the field of forensic sciences, as they could allow for 
the identification of the source of the biological material, which might be crucial to the 
investigation and prosecution of a case [1, 2, 5, 16]. 
 
 
1.3. microRNAs 
 
MicroRNAs are small endogenous, 19 to 24 nucleotides in length, single-stranded, 
non-protein coding regulatory RNA molecules that modulate cellular mRNA and protein 
levels by inhibiting protein translation or destabilizing target transcripts, usually at the 3′ 
untranslated region (UTR), through partial sequence complementation [4, 20-23]. These 
molecules play an important role in a wide range of physiologic and pathologic processes, 
having been implicated in different areas, such as immune response, neural development, 
DNA repair, apoptosis and oxidative stress response, among others [4, 22-25]. As the 
field of miRNA research keeps expanding, it has become quite clear that miRNAs regulate 
thousands of human genes, which translates in more than one third of the genome’s 
protein-coding regions [26, 27]. Furthermore, a great number of diseases have been 
associated with abnormal miRNA expression profiles: cancer, systemic lupus 
erythematosus, psoriasis, Chron's disease, diabetes, ulcerative colitis or Duchenne 
muscular dystrophy, to name a few [24]. 
Nowadays, miRNA-mediated regulation is acknowledged to represent a new 
instance of regulatory control over gene expression programs in organisms; nevertheless, 
for years, the central dogma of genetics stated that RNA played the role of messenger 
between the gene and the final proteins encoded by said gene, and non-coding RNAs 
(ncRNAs) were ignored in the field of genome sequencing [22]. Even before the discovery 
of miRNAs, it was known that a large part of the genome is not translated into proteins. 
This so called ‘junk’ DNA was thought to be evolutionary debris with no real function. 
Recently, the major advances in this research area have established miRNAs as powerful 
1. Introduction 
 
 
Extracellular microRNAs in Forensic Sciences: potential biomarkers for body fluid identification 
30 
regulators of gene expression [24]. Genome-wide transcriptional analysis has estimated 
that most transcribed mammalian genomic sequences are ncRNAs [24]. The importance 
of miRNA function is further suggested by the extreme evolutionary conservation of both 
individual miRNA sequences and the miRNA processing machinery. In addition, the 
number of miRNAs in the genome appears to be correlated with the complexity of the 
developmental program, with mammals having the largest number of miRNAs [12, 24]. 
MiRNAs were first identified in C. elegans in the early 1990s and, ever since, have 
been reported in a wide variety of organisms: from single-cell algae to humans, 
suggesting that miRNA-mediated biological function is an ancient and critical cellular 
regulatory mechanism [6, 7, 24]. To date, over 1800 human miRNA sequences have been 
identified; however, genomic computational analysis indicates that more than 50,000 
miRNAs may exist in the human genome and each may have multiple targets based on 
similar sequences in the 3'-UTR of mRNA [15, 20, 21, 24]. In fact, it has been estimated 
that more than 60% of mammalian mRNAs are targeted by at least one miRNA [24]. 
miRNAs are transcribed in much the same way as protein-coding genes. The 
majority of miRNAs are transcribed by RNA polymerase II, though a minor fraction of 
miRNAs, that lie within repetitive elements in the genome, are transcribed by RNA 
polymerase III [12]. These primary miRNA transcripts (pri-miRNAs) are often several 
hundred nucleotides long and are modified similarly to protein-coding transcripts by the 
addition of a 5’ cap and a 3’ poly-A tail [12, 24]. Pri-miRNAs are cleaved into a hairpin-
shaped 70–100 nucleotide precursor (pre-miRNA) by Drosha (a nuclear ribonuclease - 
RNase - III), which functions in a complex that contains a double-stranded (ds) RNA-
binding protein, DGCR8 (DiGeorge syndrome chromosomal region 8, known as Pasha in 
C. elegans and Drosophila). Drosha is stabilized through its interaction with DGCR8, 
which unlike Drosha, can directly and stably interact with pri-miRNAs. Pre-miRNAs are 
exported to the cytoplasm by Exportin-5 (XPO5), where Dicer (another RNase III) in 
association with a dsRNA-binding protein partner called TRBP (transactivation-responsive 
RNA-binding protein) and PACT (protein activator of PKR – in humans) processes pre-
miRNAs into a 19–24 nucleotide miRNA duplex, by removing the terminal loop [20, 28]. 
Typically, one strand of this mature miRNA duplex, termed the guide strand, associates 
with the RNA-induced silencing complex (RISC). While it is generally believed that upon 
incorporation into the RISC complex the other strand (the passenger strand) is unwound 
from the guide strand and degraded, there is also evidence that, in some cases, both 
strands of the miRNA duplex are functional. MiRNA-RISC complexes interact with mRNA 
targets through partial sequence complementation, typically within the 3’ untranslated 
region of target mRNAs. It is thought that the extent of base pairing between the miRNA 
and its mRNA target determines whether the mRNA is degraded or translationally 
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repressed [12, 24]. The strand of the miRNA complex that remains stably bound to RISC 
represents the mature miRNA, and drives RISC to the target mRNAs (Figure 1) [20]. 
 
 
Figure 1 – The biogenesis of miRNAs. Primary miRNA (pri-miRNA) transcripts are transcribed by RNA 
polymerase II and processed by the microprocessor complex (DGCR8/Drosha) into precursor stem-loop 
miRNAs in the nucleus. Precursor miRNAs (pre-miRNAs) are exported into the cytoplasm by Exportin-5 
(XPO5) and are cleaved by Dicer to produce mature miRNAs. Mature miRNAs recognize their respective 
target mRNAs and mediate post-transcriptional repression of their targets through translational repression, 
deadenylation or enhanced mRNA decay. (Adapted from Yates et al. [28]). 
 
When compared to protein-based biomarkers, miRNAs offer several advantages: 
the complexity of miRNAs is low, the miRNAs are stable in various body fluids and, the 
expression of some miRNAs are restricted to specific tissues or biological stages [12, 21]. 
The levels of miRNAs can also be easily measured by various commonly used laboratory 
methods, for instance assorted signal amplification strategies [5, 12, 18, 21, 29]. 
While a vast majority of miRNAs are found intracellularly, a significant number of 
miRNAs have been observed outside of cells, including in various body fluids [12, 24]. 
These miRNAs are stable and show distinct expression profiles in different types of fluids 
[12, 24]. Given the instability of most RNA molecules in the extracellular environment, the 
presence and apparent stability of miRNAs is interesting. Urine and other body fluids are 
known to contain RNases, which suggests that secreted miRNAs are likely packaged in 
some manner, to protect them against RNase digestion [24]. The small size of mature 
miRNAs and their tight relationship with the RISC complex may lead to a lesser 
susceptibility to moisture, ultraviolet (UV) light, temperature, suboptimal environmental pH 
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and other factors that often degrade mRNA beyond its usability, hindering the work of 
forensic investigators [4, 11, 22]. 
One question that often arises in the forensic field is whether miRNAs can be 
considered good biomarkers for body fluids. An ideal biomarker should fit a number of 
criteria depending on how the biomarker is to be used. It needs to be available to be 
analyzed through non-invasive methods; have a long half-life in samples; be unalterable 
by physical or chemical factors; it should be specific to a tissue; but most of all, it should 
be able to be analyzed by a fast, simple, accurate, reproducible and economical method 
[4, 12].  
Following the discovery of extracellular miRNAs in plasma and serum, a series of 
studies have consistently revealed the presence of miRNAs in other body fluids (namely 
saliva, urine, breast milk, seminal plasma, tears, amniotic fluid, colostrum, bronchial 
lavage, cerebrospinal fluid, peritoneal fluid, and pleural fluid) [4, 8, 9]. However, there is 
no common opinion regarding the origin, biological function or specific expression patterns 
of extracellular miRNAs. Turchinovich and co-workers state this could be the 
consequence of extracellular miRNAs not being a homogeneous population and existing 
in differently packaged forms [8]. 
According to Silva and colleagues, the lack of homogeneity and the non-
reproducibility of results from different groups trying to determine if miRNAs can be 
considered a good biomarker for body fluids, highlights the necessity for a standardization 
for miRNA biomarker assessment [4]. 
A study performed by Weber and co-workers showed that several miRNAs are 
common to different biological fluids; however, in their study, plasma and urine shared the 
fewest number of commonly detectable miRNA species [9]. The study suggests that a 
majority of the circulating miRNAs were either picked up by the kidneys or destroyed in 
the urine; nevertheless, the pathway taken by urine through the urinary system may also 
contribute to this difference [9]. To date, no miRNA was detected as a biomarker for urine 
or plasma identification, which are very important human fluids in forensic sciences [4, 9].  
 
 
 
 
 
 
 
 
 
1. Introduction 
 
 
Extracellular microRNAs in Forensic Sciences: potential biomarkers for body fluid identification 
33 
1.3.1. Extracellular microRNAs 
 
To this date, the origin and function of circulating miRNAs is still not systematically 
elucidated [8, 9, 30, 31]. However, according Mlcochova and co-workers, the cell-to-cell 
communication hypothesis, based on the export of miRNAs, seems to be the most 
satisfying explanation for the existence of extracellular miRNAs [31]. This group also 
describes two potential secretory mechanisms that may justify the presence of miRNAs in 
urine. The first, a passive process influenced by stress factors, causing a rupture in the 
cell and leaking the miRNAs to the extracellular space. The second pathway is the active 
secretion of miRNAs through microvesicles. Generally, microvesicles include 
microparticles and exosomes [31]. Turchinovich and colleagues also state that 
extracellular miRNAs can be encapsulated in microvesicles [8]. According to this group, 
three types of membranous vesicles can contain extracellular miRNAs, namely apoptotic 
bodies, shedding vesicles and exosomes [8]. Furthermore, Turchinovich’s group mentions 
that extracellular miRNAs can also be vesicle free and associated with either AGO 
(Argonaute) proteins or be incorporated into high-density lipoprotein (HDL) particles, 
although it is not clear whether the miRNAs are incorporated inside these particles or 
adsorbed on their surface (figure 2) [8].  
 
 
Figure 2 – Possible secretory mechanisms of extracellular miRNAs and modes of extracellular miRNA 
packaging. HDL: high-density lipoprotein particles. Ago: Argonaute protein. (Adapted from Turchinovich et al. 
and Mlcochova et al. [8, 31]). 
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Apoptotic bodies are particles that can contain various cellular organelles (including 
mitochondria and nuclei), ranging between 1 and 4 µm, and remain after programmed cell 
death, being byproducts of apoptosis [8]. It should be noted that some authors do not 
acknowledge miRNAs entrapped in apoptotic bodies as circulating miRNAs, as the size of 
these particles is comparable to that of cell debris or blood platelets and, most protocols 
commonly used in extracellular miRNA research involve the removal of both cell debris 
and apoptotic bodies [8, 32]. 
Shedding vesicles are heterogeneous in size (between 0.1 and 1 µm), and are 
formed by outward budding and fission of the plasma membrane, thus being limited by a 
lipid bilayer [8, 30]. They belong to the same class of microvesicles as exosomes, 
although they differ in size, content and mechanism of generation [8].  
Exosomes are membrane-bound nanovesicles of endosomal origin, released by 
cells upon fusion of multivesicular bodies with the plasma membrane [33-35]. Exosomes 
are present in a wide number of biological fluids, including blood and urine, ranging 
between 30 and 100 nm in diameter and have a limiting lipid bilayer, transmembrane 
proteins and a hydrophilic core containing proteins, DNA, mRNAs and miRNAs [33-37]. 
Exosomes can act as extracellular vehicles by which cells communicate through the 
delivery of their functional cargo to recipient cells, with many important biological, 
physiological and pathological implications [34-36]. 
 
 
1.3.2. Blood and urinary microenvironment: microRNA content 
 
One of the most common types of body fluids found in crime scenes, particularly 
those of a violent crime, is blood [2].  
Blood can be considered a complex liquid tissue comprising cells and extracellular 
fluid and provides the major link between cells and tissues in an organism [38]. Blood 
samples are relatively easy to obtain, technically and psychologically easy to process, and 
are mostly considered homogeneous [39]. 
Most of the current blood biomarkers, besides not being specific for the identification 
this fluid, are based on the levels of specific proteins in the blood, such as troponin 
associated with cardiovascular conditions, carcinoembryonic antigen for various cancers, 
prostate specific antigen for prostate cancer, and aminotransferases (alanine 
aminotranferase and aspartate aminotransferase) for liver function [12]. According to 
Wang and co-workers, these biomarkers are also inadequate in specificity and sensitivity 
for definitive disease diagnosis [21]. Furthermore, protein-based biomarkers may have 
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different post-translational modifications, which can affect the accuracy of measurement; 
therefore, there is a need for the discovery of new blood biomarkers [12]. 
MiRNA species are relatively homogenous and several reports state that miRNAs 
have a stable expression in plasma [5, 9, 10, 12, 40-42]. 
If a blood sample, removed from the circulatory system via venipuncture, is 
withdrawn in the presence of an anticoagulant and centrifuged to remove cellular 
elements, a plasma sample is obtained. [25, 39]. 
In a study by Wang and co-workers, using serum and corresponding plasma 
samples from the same individuals, it was observed higher miRNA concentrations in 
serum samples compared to the corresponding plasma samples [21]. The difference 
between serum and plasma miRNA concentration showed some associations with miRNA 
from platelets, which may indicate that the coagulation process may affect the spectrum of 
extracellular miRNAs in blood [21]. The group suggests that there are a number of factors 
that might affect the measurement of circulating miRNA concentration and that caution 
must be taken when comparing miRNA data generated from different sample types or 
measurement platforms [21]. In Wang’s study, as the serum and plasma were collected at 
the same time from the same individuals, the higher miRNA concentration in serum 
suggests that additional miRNA was released from cells during the coagulation process. 
Cell lysis, especially from the highly abundant red blood cells, during the coagulation 
process is one of the plausible explanations for this concentration difference between 
serum and plasma. Wang and colleagues also added that the miRNA concentration 
difference between serum and plasma showed some associations with the miRNA 
spectrum in platelets and white blood cells, instead of the most abundant cell population, 
red blood cells, in the blood [21]. The miRNA concentration difference between serum and 
plasma is consistent with the idea of miRNA ‘trafficking” between cellular compartments 
and the extracellular environment [21, 43]. It is known that during the coagulation process, 
blood cells are exposed to a “stressful environment” which may “stimulate” the release of 
certain miRNAs and other RNAs [21, 41]. Wang’s miRNA study yielded a similar 
conclusion and suggests that plasma may be the sample of choice in studying circulating 
miRNAs, since miRNAs released during the coagulation process may change the true 
repertoire of circulating miRNAs [21]. 
When compared with mRNA and other cellular RNAs, miRNAs have shown a high 
degree of stability, in urine, for reasons that are yet unknown [44]. The harsh urinary 
environment, particularly the urea content and the levels of ammonia and pH (normal 
values range from pH 4.6 to pH 8.0) might interfere and ultimately destroy miRNAs in 
urine; however, to the best of our knowledge no studies have been reported concerning 
this subject. 
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Even though urine contains abundant nucleases, several studies have reported 
miRNAs to be identifiable in urine, with their stability attributed to nuclease resistance due 
to their small size, being bound to proteins and/or microvesicular containment [44].  
Nucleases can be regarded as molecular scissors, which cleave phosphodiester 
bonds between the sugars and the phosphate moieties of DNA. They contain conserved 
minimal motifs, which usually consist of acidic and basic residues forming the active site. 
These active site residues coordinate catalytically essential divalent cations, such as 
magnesium, calcium, manganese or zinc, as a cofactor. Cleavage reactions occur either 
at the end or within DNA and thus DNA nucleases are categorized as exonucleases and 
endonucleases, respectively. Exonucleases can be further classified as 5' end processing 
or 3' end processing enzymes, according to their polarity of consecutive cleavage [45]. 
Human extracellular RNases, together with other members of the mammalian RNase 
superfamily, can be classified into four different enzyme types on the basis of their 
structural, catalytic and/or biological properties. Their occurrence and main distinctive 
features have been described and their catalytic differences (action on single- and double-
stranded RNAs, dependence of enzyme activity on pH, ionic strength and cations, and 
hydrolysis of cyclic nucleotides) have been comparatively analyzed and discussed by 
Sorrentino and colleagues [46]. Many members of this superfamily have important 
biological actions including neurotoxicity, angiogenic activity, immunosuppressivity and 
antitumor activity. Some nondigestive extracellular RNases also serve as cytotoxic agents 
in host defense in higher plants and mammals and their potential use as therapeutic 
agents for human disorders has been suggested [46, 47]. 
It is known that microvesicles are impermeable to RNases, a hypothesis which 
might explain the stability of miRNAs in urine, since this fluid has a very high level of these 
enzymes [8, 31]. However, not all miRNAs detected in urine samples are protected within 
microvesicles and, this phenomenon seems to be common among body fluids. Studies 
performed by Turchinovich and colleagues, using blood samples revealed that a majority 
of the nuclease-resistant extracellular miRNAs, in plasma and cell culture media, were 
floating outside exosomes and bound to the Ago2 protein (protein of the Argonaute family) 
[8, 32]. To further confirm the binding of extracellular miRNAs to Ago2 protein in blood 
plasma and conditioned media (the medium in which the cells were being cultured), 
Turchinovich’s group subjected anti-Ago2 and control immunoprecipitates to relative 
quantification. This study showed that miRNAs were detected in anti-Ago2 
immunoprecipitates while control immunoprecipitates (containing no anti-Ago2) were 
almost totally free of miRNAs [32]. During intracellular miRNA synthesis, all mature 
miRNAs become associated with one of the four Ago proteins; therefore, it is not entirely 
surprising that extracellular miRNAs could be coupled with the same proteins. The 
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remarkable stability of the Ago2 protein could explain the stability of associated miRNAs, 
especially when compared with mRNAs, thus allowing for a superior discriminatory 
potential in nuclease and protease rich environments [4, 32].  
Proteomic analysis of miRNA-containing supernatants from cells cultured in vitro 
revealed that a number of other RNA binding proteins, such as nucleophosmin-1 and 
ribosomal protein L10a and L5, were found bound to miRNA outside of any vesicles. 
Researchers state that the physical interaction of miRNAs with these protein complexes, 
in the extracellular space, significantly protects them from extracellular nucleases [48].  
In order to test the possibility that urinary miRNAs are associated with urinary 
proteins or whether they exist as an integral component of proteins on the exterior of 
exosomes, Mall and colleagues, assessed the effect of trypsin digestion on the quantity of 
urinary miRNAs [44]. This study showed that there was no change in the levels of the 
miRNAs assessed; thus, according to the authors, the unusual stability of urinary miRNAs 
is not due to its association with exosome-bound structures or macromolecules in urine 
[44]. Moreover, Mlcochova and co-workers also suggest that miRNAs might be associated 
and stabilized by miRNA binding complexes, such as RISC or chemical modifications 
including methylation, adenylation or uridylation might increase miRNAs stability [31]. 
 
 
1.4. How to Identify Body Fluid Stains in crime scenes? 
 
1.4.1. Blood 
 
As previously mentioned, blood is one of the most common body fluid encountered 
at crime scenes [2]. The simplest test that crime scene investigators use to detect 
bloodstains that are not clearly visible is an alternate light source (ALS), such as UV light 
[2]. This method is especially helpful when the stain is on a dark background. An ALS can 
direct attention to a latent stain at a crime scene, and then further presumptive tests can 
be used to form more conclusions about any body fluids that are present. However, these 
light sources must be used with caution, since certain UV wavelengths can damage the 
DNA enough that none is detected during polymerase chain reaction (PCR) – short 
tandem repeat quantification and amplification [2, 49]. 
The luminol test is another presumptive blood test that investigators quite often use 
at a crime scene [50]. It is based on the ability of hemoglobin and its derivatives to 
enhance the oxidation of luminol, in the presence of an alkaline solution, and involves 
spraying a suspected area with an aqueous solution of luminol and an oxidant [2]. It is 
known to be the most sensitive of the current presumptive tests used today, and there are 
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also several formulations available that have advantages and disadvantages regarding 
sensitivity, intensity and duration of illumination, and effect on subsequent DNA analysis 
[2, 51, 52]. 
A very popular presumptive catalytic method is the phenolphthalein test which is 
also known as the Kastle-Meyer test [2]. Phenolphthalein will cause an alkaline solution to 
turn pink after its oxidation by peroxide, when blood is present. Although it is not as 
sensitive as luminol, using it on other body fluids does not yield a positive result [2, 19]. 
 
 
1.4.2. Urine 
 
Urine is a difficult body fluid to detect due to the low sensitivity of the tests available 
and false positive results [2]. An accurate identification of this fluid can specially be useful 
in sexual assault, harassment, and misconduct cases. 
As is the case with other fluids, urine will fluoresce when exposed to UV light; thus 
this is not a specific identification method for urine identification. Additionally,  urine is 
especially hard to locate as nature of this fluid causes it to spread out so the stains tend to 
be more diluted than in other body fluids, which makes them fluoresce much less [2]. Odor 
could be an indicator, but it will cover an entire item and not localize itself to the stained 
area [2]. Other basic microscopic methods have been established, relying on the 
presence of solids in the sample, namely various crystalline materials and epithelial cells 
characteristic of the urinary tract linings. This only gives useful results in liquid samples 
not in stains, and as a result has a limited usefulness to forensic cases [2]. 
Inorganic ions such as chloride, phosphate, and sulfate have also been used to 
identify urine [2]. These ions are not unique to urine, but phosphate and sulfate are 
present in much higher concentrations in urine than in other body fluids.  
Urea is an organic compound that is also found in higher concentrations in urine [2, 
53]. Tests for urea depend on the activity of the enzyme urease as it enzymatically 
decomposes urea to ammonia and carbon dioxide [53]. The ammonia can then be 
detected by either using Nessler’s reagent as an indicator (the solution becomes deeper 
yellow in the presence of ammonia) or p-dimethylaminocinnamaldehyde (development of 
a yellowish-green color) [53]. The radial gel diffusion test can also be used to detect the 
presence of urine, and this technique uses urea and a bromothymol blue indicator [2, 53]. 
The ammonia produced during urease activity alters the pH (making it alkaline), changing 
the color of the indicator in the agar from yellow to blue [54]. This method is both 
qualitative and quantitative, with the diameter of the reaction circle being proportional to 
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the square root of the urea concentration; nonetheless, semen and sweat stains lead to 
slight false-positive results, due to their urea content [2, 55].  
 
 
1.5. microRNAs detected in blood and urine samples: potential new biomarkers 
for fluid identification 
 
In recent years, researchers have been trying to establish a link between specific 
miRNA patterns and body fluid identification, as it is known that miRNAs are differentially 
expressed in these fluids [9, 10, 42, 56, 57].  
A systematic review of the literature revealed three miRNAs that show the potential 
to be forensic biomarkers: miR-801, miR-369-3p and miR-323b-5p.  
According to a study performed by Weber and co-workers, that analyzed the 
presence of miRNAs in twelve body fluids (plasma, saliva, tears, urine, amniotic fluid, 
colostrum, breast milk, bronchial lavage, cerebrospinal fluid, peritoneal fluid, pleural fluid 
and seminal fluid), the presence of miR-801 was only detected in plasma samples [9]. 
Moreover, Schwarzenbach and colleagues, revealed that the expression levels of miR-
801 were elevated in plasma samples of breast cancer patients in comparison to healthy 
individuals [58]. However, these authors also found the presence of this miRNA in plasma 
samples of healthy individuals. According to Zhou and co-workers, miR-801 levels in 
plasma allow the differentiation between healthy individuals and patients with 
hepatocellular carcinoma (HCC), since there is an elevated expression of this miRNA in 
patients with HCC compared to the healthy individuals [59]. Additionally, Madhavan and 
colleagues also compared the miR-801 plasmatic levels in several individuals, and 
concluded that patients with metastatic breast cancer had much higher plasma levels of 
this miRNA than the healthy individuals [60, 61]. The literature provides little information 
about miR-801. Weber’s was the only group, to the best of our knowledge, that has 
studied this miRNA using only healthy individuals; all other information available is 
regarding the study of miR-801 in those afflicted with some kind of pathology. This “blank 
slate” concerning miR-801 makes it a very interesting miRNA to study. Besides, all these 
studies have detected the presence of miR-801 in the plasma of healthy individuals, which 
is a strong indicator that this miRNA is expressed in plasma [58-61]. 
Weber’s miRNA research has shown that miR-369-3p was only detected in plasma 
samples [9]. Moreover, Guo and co-workers showed that miR-369-3p levels in the serum 
and skin of psoriasis’ patients are higher than in healthy subjects, but the authors stress 
the need for further studies in order to clarify the role of this miRNA in the pathogenesis of 
psoriasis [62]. Upon reviewing the literature, no articles were found that systematically 
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showed the presence of miR-369-3p in the urine, so it is considered that it may be 
advantageous to conduct a more detailed analysis of this miRNA. 
According to Gildea and colleagues, urinary miRNAs are composed of a 
combination of both filtered miRNAs (derived from the blood) as well as kidney-derived 
miRNAs [63]. Several reports have shown that miR-323b-5p regulates the Claudin-16 
protein, which is essential for maintaining the permeability of the thick ascending limb of 
Henle's loop [64, 65]. Studies with Claudin-16 deficient mice, showed calcium and 
magnesium loss in the kidney as well as nephrocalcinosis; therefore, it can be surmised 
that miR-323b-5p is a key miRNA in normal kidney function. Moreover, Argyropoulos and 
co-workers compared urine samples from patients with and without diabetic nephropathy 
and determined that the expression of miR-323b-5p was higher in those with diabetic 
nephropathy [66]. This group also suggests that the onset of microalbuminuria is 
associated with reduced levels miR-323b-5p [66]. Additionally, miR-323b-5p has never 
been identified in plasma samples which could mean this miRNA has the potential to be a 
biomarker for urine identification. It is important to highlight that miR-453 is processed 
from the 5p arm of miR-323b and although the correct designation is miR-323b-5p, 
sometimes ‘miR-453’ is still found in the literature [15].  
MiR-801, miR-369-3p and miR-323b-5p were thus chosen for the present study, in 
order to evaluate if they can be forensically relevant miRNAs, as well as to prove that 
these miRNAs can be used for the identification plasma and urine samples. There is a 
shortage of studies comparing the miRNA signatures of plasma and urine, body fluids that 
are so common in forensic scenarios; therefore, knowing the miRNA behavior pattern for 
each fluid and finding suitable miRNA biomarkers for them could represent a 
breakthrough for the field of forensic sciences. 
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2. Objectives 
 
 
2.1. Main objective 
 
The main objective of the present study is to identify a miRNA profile useful for 
plasma and urine sample identification.  
 
 
2.2. Specific objectives 
 
- Systematic review of the literature regarding the origin and expression profiles of 
extracellular miRNAs in plasma and urine samples; 
 
- Detection and relative quantification of circulating miR-801 and miR-369-3p in 
plasma samples; 
 
- Detection and relative quantification of circulating miR-323b-5p in urine samples; 
 
- Establishing a miRNA profile associated with plasma and urine identification. 
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3. Material and Methods 
 
 
3.1. Study Population 
 
A miRNA expression profiling study was conducted in twenty-two healthy adult 
individuals (five males and seventeen females) from the North of Portugal. This study 
group includes random Caucasian individuals with a mean age of 46.6 ± 17.78 years, a 
median age of 48.5 and with no major pathological condition. 
Peripheral venous blood (6ml) and urine (30 ml) samples were collected from each 
subject after obtaining a written informed consent, according to the Helsinki Declaration 
principles. 
 
 
3.2. Sample processing 
 
Once the biologic samples were collected, they were processed according the 
following experimental conditions: 
In urine samples, the pellet resulting from a 20 minute centrifugation at 3000 rpm, at 
room temperature, was diluted with 1X PBS (Phosphate buffered saline) and then 
centrifuged for 15 minutes at 3000 rpm, at room temperature. The pellet was then 
stabilized with TriPure® Isolation Reagent (Roche Applied Science®) and preserved at -80 
ºC, until molecular analysis.  
Regarding the plasma samples, after being collected into anticoagulant-treated 
tubes, the whole blood samples were processed. Initially, the blood samples were 
submitted to a centrifugation, at 2500 rpm during 5 minutes, at room temperature, to 
separate the plasma fraction. Following centrifugation, the plasma was then stored at -80 
°C, until molecular analysis. 
 
 
3.3. microRNA extraction 
 
MiRNA extraction was performed for urine and plasma samples, using the GRS 
microRNA kit (Grisp®) according to manufacturer instructions. Some modifications were 
performed in the experimental procedures, namely the lysis buffer wasn’t added and 14μl 
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of miRNA buffer as well as 70μl of phenol-chloroform were used in urine samples, and 
35μl of miRNA buffer and 385μl of phenol-chloroform were added to the plasma samples. 
 
 
3.4. cDNA synthesis and relative quantification by real-time PCR 
 
After miRNA extraction, RNA concentration and purity were measured for each 
sample, at 260 nm and 280 nm using the NanoDrop® ND-1000 spectrophotometer. The 
miRNA samples (5μl) were then used as templates for cDNA synthesis using a 
Taqman®MicroRNA Reverse Transcription kit (Applied Biosystems®), according to the 
manufacturer’s instructions, and sequence-specific stem-loop primers for miR-801, miR-
369-39, miR-323b-5p and RNU48, which was used as an endogenous control. 
MiRNA expression was analyzed by quantitative real-time PCR (qPCR). The 
reactions were carried out on a StepOneTM qPCR Real-Time PCR machine, containing 1X 
TaqMan® Fast Advanced Master Mix (Applied Biosystems®), with 1X probes to amplify the 
target miRNAs (Taqman® microRNA Expression Assays, miR-801: 001994, miR-369-3p: 
000557, miR-323b-5p: 002318), cDNA sample (2.6μl) and RNU48 (RNU48: 001006, 
Applied Biosystems®). During qPCR amplification, the samples were subjected to 95 ºC 
for 20 seconds and then 40 cycles of 95 ºC for 1 second, followed by 60 ºC for 20 
seconds. MiRNAs detected in samples above the 40 cycle detection limit were labeled as 
negative samples, following the Applied Biosystems StepOne™ Real-Time PCR Systems 
Guideline for standard cycling. The miRNA quantifications were performed in duplicate 
and negative control lacking cDNA was included in all reactions. The results were 
confirmed by two independent investigators.  
qPCR is the optimal approach for assessing circulating miRNAs, as it is a simple 
tool to efficiently determine the amount of a gene transcript in a sample [29]. In qPCR, 
reactions are characterized by the point in time during cycling when amplification of a 
target is first detected, the cycle threshold (Ct), rather than the amount of target 
accumulated after a fixed number of cycles [67]. By definition, the Ct indicates the 
fractional cycle number at which the amount of amplified target reaches a fixed threshold 
[67, 68]. The higher the starting copy number of the nucleic acid target, the earlier a 
significant increase in fluorescence is observed [68].  
The fluorescent PCR amplification marker chosen for a qPCR reaction is vital, as it 
will determine the specificity and sensitivity of the assay [29]. In a heterogenous, yet 
closely related RNA species such as miRNAs, specificity is a most important factor [29].  
SYBR® green, an asymmetrical cyanine dye, binds to nucleic acids, especially 
double stranded DNA molecules, with high affinity but no specificity. As the PCR reaction 
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generates more amplicons, SYBR® green will bind and create a net increase in 
fluorescence. The main disadvantage of this dye is its lack of specificity, as it may 
generate false positives through the binding to nonspecific DNA fragments (e.g. primer 
dimers or multiple dye molecules may bind to one amplicon), increasing the perceived 
quantity; thus, SYBR®-based chemistries are best to be avoided when performing miRNA 
quantifications [29, 69].  
Fluorophore-tagged probe-based chemistry, such as TaqMan® assays, provides 
several advantages over SYBR® green or dye-based technologies. TaqMan® probes, 
which are designed to hybridize to an internal stretch of the amplicon, contain a 
fluorescent reporter and quencher upon adjacent nucleotides [69]. The close proximity of 
the fluorescent reporter to its quencher molecule prevents the emission of fluorescence 
[69]. Since the expression of the appropriate fluorescence is regulated and obtained after 
amplification of a specific complementary DNA, barely any background fluorescence is 
obtained, hence offering a better signal to noise ratio [29]. The high level of specificity 
(specific to target copy accumulation during PCR), sensitivity (low copy detection) and 
reproducibility make TaqMan® assays the superior choice for the quantification of 
circulating miRNAs [29]. For this reason, we choose to use it for all qPCR reactions. 
 
 
3.5. Statistical Analysis 
 
Data analysis was made using StepOneTM Sofware v2.2 (Applied Biosystems®) with 
the same baseline and threshold set for each plate, in order to generate Ct values for all 
the miRNAs in each sample. 
Relative quantification of miRNA expression was performed by the delta Ct (ΔCt) 
method using the average expression of the reference control gene for normalization of 
the miRNA abundances across the fluids. All Ct values were used to obtain ΔCt values for 
each of the miRNAs analyzed, applying the formula:  
 
 
ΔCt = Cttarget miRNA - Ctendogenous 
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Statistical analysis was performed using IBM®SPSS®Statistics software for Windows 
(Version 22.0). The relative fold change (according to Livak and Schmittgen, as 2-ΔΔCt) and 
the Student's t-test were also calculated in order to evaluate the differences in the 
expression levels of the normalized miRNAs, where [70]: 
  
 
ΔΔCt̅̅ ̅̅ ̅̅  = ΔCt̅̅ ̅̅̅ Plasma - ΔCt̅̅ ̅̅̅ Urine 
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4. Results 
 
 
4.1. microRNA detection frequencies in plasma and urine samples 
 
Figure 3 displays an overview of each miRNA detection frequency, that is, the 
percentage of samples in which each of the tested miRNAs was found. 
In the twenty-two plasma samples analyzed, the miR-801 was found in all samples 
(100%). However, this miRNA was only detected in 80% of urine samples. Following the 
same trend, the miR-369-3p was detected in 91% of plasma samples, and its presence 
was only detected in 20% of urine samples. MiR-323b-5p was detected in 86% of the 
analyzed plasma samples, whilst its detection frequency in urine samples was of 75%. 
 
 
Figure 3 – miRNA detection frequency, in percentage, of miR-801, miR-369-3p and miR-323b-5p, in 
plasma and urine samples. 
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4.2. microRNA relative quantification levels in plasma and urine samples 
 
A graph with the relative quantification of each miRNA was performed for each body 
fluid (Figure 4). 
 
 
Figure 4 – Relative quantification levels of miR-801, miR-369-3p and miR-323b-5p, found in plasma 
and urine samples. (Mean ± Standard Error Mean; *P< 0.001). 
 
The relative quantification level of miR-801, in plasma and urine samples, is higher 
than the expression level of the other miRNAs tested. However, the graph shows no 
statistically significant differences in the miR-801 expression levels between the plasma 
and urine. 
Regarding the miR-369-3p, we observed that this miRNA exhibits a higher relative 
expression in plasma samples when compared to urine samples (P< 0.001).  
Concerning the miR-323b-5p, according to our results, we did not observe any 
differences in the expression levels between the plasma and urine samples.  
The relative fold change was also calculated (table 1), as 2-ΔΔCt. Table 1 indicates 
that, from the three miRNAs studied, miR-369-3p is the only with a statistically significant 
difference in expression between plasma and urine (P< 0.001). This miRNA exhibited a 
37.52 fold-change in plasma when compared to urine samples. 
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Table 1 – Fold Change values for miR-801, miR-369-3p and miR-323b-5p. 
 miR-801 miR-369-3p miR-323b-5p 
ΔΔCt 0.27 -5.23 0.4 
Fold Change* 
(Plasma - Urine) 
0.829 37.52 0.758 
P-value** 0.768 <0.001 0.715 
 
*2
-ΔΔCt
; ** Student's t-test 
 
 
4.3. microRNA expression profile according to gender 
 
In the present study, we also tested the miR-801, miR-369-3p and miR-323b-5p 
expression levels according to gender. Figure 5 displays an overview of the miRNAs 
relative quantification levels within male and female.  
 
 
Figure 5 – Relative quantification levels of miR-801, miR-369-3p and miR-323b-5p according to 
gender. (Mean ± Standard Error Mean). 
 
Analyzing the plasma samples’ results, there were not any significant statistical 
difference in the miRNAs expression levels for either gender (miR-801: P= 0.708; miR-
369-3p: P= 0.857; miR-323b-5p: P= 0.595). The same result was found for urine samples, 
as no significant statistical difference between the male and female samples was 
observed (miR-801: P= 0.405; miR-369-3p: P= 0.718; miR-323b-5p: P= 0.527). However, 
it should be mentioned that miR-369-3p was only detected in two urine male samples, 
whereas it was detected in fourteen female urine samples. 
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4.4. microRNA expression profile according to age 
 
In order to assess a possible link between age and the miRNAs expression levels 
for each biological fluid, a graph was obtained (Figure 6). 
 
 
Figure 6 – Relative quantification levels of miR-801, miR-369-3p and miR-323b-5p according to age. 
(Mean ± Standard Error Mean; *P= 0.037; **P= 0.018). 
 
Taking into account the median age, it allowed for the definition of two age 
categories: <48 years and ≥ 48 years. 
In urine samples, the miR-369-3p showed a significant statistical difference between 
the two age groups, as the older group showed higher miR-369-3p levels than the 
younger individuals (P= 0.018). MiR-369-3p also exhibited a higher relative expression in 
the plasma of the older individuals (≥ 48 years), thus a significant statistical difference was 
observed for this miRNA in plasma samples (P= 0.037). The relative quantification of the 
miR-801 and miR-323b-5p, in plasma, revealed no significant statistical differences 
between the two study groups defined (miR-801: P= 0.522; miR-323b-5p: P=0.161). In 
urine samples, there was also no significantly statistical differences, between the age 
groups, observed for miR-801 and miR-323b-5p (miR-801: P= 0.125; miR-323b-5p: P= 
0.419). 
 
-14
-12
-10
-8
-6
-4
-2
0
2
4
m
iR
N
A
 r
e
la
ti
v
e
 q
u
a
n
ti
fi
c
a
ti
o
n
  
(-
Δ
C
t)
 
Plasma 
<48 years
≥ 48  years 
Urine 
* 
** 
  
  
Discussion 
 
  
  
5. Discussion 
 
Extracellular microRNAs in Forensic Sciences: potential biomarkers for body fluid identification 
59 
5. Discussion 
 
 
In the field of forensic sciences, there is a great need to find an accurate and reliable 
biomarker for the identification of body fluids. Recently, it was found that miRNAs could be 
the potential answer, providing additional information that might assist with the 
identification of forensically relevant biological stains; which, in time, could prove to be 
particularly useful in the analysis of compromised and degraded samples, that are 
frequently encountered in forensic investigations.  
In the present study, when analyzing the relative quantification levels of miR-801, 
we found there was no statistically significant difference between the two fluids (P= 
0.768). We were testing miR-801 to see if it could be a biomarker for plasma as evidences 
found in the literature stated this miRNA was detected in plasma samples of healthy 
individuals, and it had not been previously identified in urine samples; therefore, our 
results contrast with what has been published so far in the literature. A study performed by 
Weber and co-workers, tested twelve human body fluids from five healthy individuals and 
found that miR-801 was only present in plasma samples [9]. Our results aren’t on par with 
Weber’s observations; nevertheless, it should be taken into account that the number of 
samples we tested (twenty-two samples) is higher than the one tested by Weber’s groups, 
and this could explain the detection of miR-801 in urine samples [9]. These results also 
emphasize the importance of a large number of biologic samples in miRNAs profiling 
studies. To our knowledge, the present study is the first to identify miR-801 in urine 
samples, so we suggest further studies with a higher number of samples, in order to 
validate these results.  
According to our results, we observed that miR-369-3p exhibits higher expression 
levels in plasma samples when compared to urine (P<0.001). These findings were in 
accordance with the literature, since in several studies the miR-369-3p has been 
previously detected in plasma and serum samples but not in urine [9, 62]. Thus, we can 
hypothesize that miR-369-3p could be a molecular biomarker, allowing to establish the 
identity of body fluids in forensic sciences. 
Concerning the miR-323b-5p, when comparing its expression levels between the 
two body fluids, we did not find any statistically significant differences (P= 0.715). MiR-
323b-5p has been described in the literature as playing a vital part in maintaining proper 
kidney function, so it was to be expected for this miRNA to have a higher detection 
frequency in urine samples, and for its expression levels between the two fluids to be 
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statistically significant [64, 65]. To date, there are no reports of miR-323b-5p being 
identified in any blood fraction, making the present study the first to identify it.  
A systematic review of the literature highlights the existence of miRNAs that are 
gender specific in an healthy population [4, 21, 71, 72]. For instance, a 2013 study 
assessed the link between circulating serum miRNAs with metabolic syndrome (MetS) 
and connected it to gender [4, 72]. This group confirmed a significant change in the 
miRNA profile, which was overexpressed in the serum of individuals with MetS and more 
prominent in women [4, 72]. This relationship some miRNAs have with gender points out 
the need to choose proper miRNAs as biomarkers for body fluids, along with a need to 
understand more about the expression behavior of extracellular miRNAs.  
We observed that in the two fluids analyzed, none of the miRNAs we tested showed 
any significant statistical differences in their expression levels for either gender. 
Interestingly, miR-369-3p was only detected in two urine samples from male individuals 
versus fourteen urine samples from women. Therefore, it is necessary to perform future 
studies using a higher number of samples to replicate these results, as well as to 
determine if there could be a link between miR-369-3p and gender.  
It is also known that the expression levels of some miRNAs vary with age. In a 2011 
study performed by Li and co-workers, the expression of miRNAs in rat liver during aging 
was studied, and the group observed that miR-34a and miR-93 levels increased in middle 
and old-age rat liver when compared to young rats [4, 73]. Maes and colleagues also 
researched the expression levels of miRNAs in rat liver and proved that a gradual 
increase of miR-669c and miR-709 was observed from the mid-age (18–33 months), 
whereas miR-93 and miR-214 levels are increased in extremely old (33 months) mice [4, 
74]. Other similar studies were done in mice tissues by Hamrick et al. and Drummond and 
co-workers [4, 75, 76].  
In our study, miR-801 and miR-323b-5p showed no statistically significant 
differences, for either fluid, between the two age groups analyzed. However, miR-369-3p 
showed higher expression levels in plasma and urine samples from older individuals (≥ 48 
years). A study performed by Li and co-workers, in which the role of miRNA regulation in 
mice brain during the normal aging process was evaluated, found that the expression 
levels of miR-369-3p were higher in older mice (33 months) than in younger ones (10 
months), which corroborates our findings [77]. The group also stated that ubiquinol-
cytochrome c reductase, or Rieske iron-sulfur protein (UQCRFS1) is targeted by miR-369-
3p. UQCRFS1 is a key subunit of the cytochrome bc1 complex of the mitochondrial 
respiratory chain, and a deficiency in this component may result in a decline of efficient 
adenosine triphosphate (ATP) production [77, 78]. Since, oxidative phosphorylation is 
known to decline and suffer loss of efficiency in aging tissues, it could be suggested that 
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the high levels of miR-369-3p are connected to low levels of UQCRFS1, and consequently 
to older individuals. Most published studies analyzing a connection between miR-369-3p 
and age, either use animal models or unhealthy individuals; for that reason, it would be 
interesting to carry out further studies using healthy individuals in order to ascertain if 
there is, in fact, a connection [77-79].  
As previously mentioned, miR-369-3p was only detected in two male urine samples, 
which can indicate that this miRNA may play a more relevant role in women and that the 
difference in expression levels observed between the age groups, is mostly due to our 
female population. For that reason, we suggest that in the urine samples, the difference 
between the age groups might be due to hormonal changes caused by menopause 
(average age is 51 years old) [80]. In menopause, the loss of ovarian follicular activity is 
responsible for low and stable levels of progesterone and estradiol, which leads to a 
significant increase in the follicle stimulating hormone (FSH) and the luteinizing hormone 
(LH) levels and the permanent cessation of menstruation, resulting in the end of the 
natural female reproductive life [81]. 
In a study by Zhao and co-workers, miRNAs were extracted from endometrial 
samples of women that underwent luteal phase support using steroid hormones, namely 
micronized progesterone and 17-beta-estradiol [82]. The results showed that the 
expression levels of miR-369-3p were associated with vascular endothelial growth factor 
(VEGF), a predicted target gene, as well as higher levels of micronized progesterone and 
17-beta-estradiol [82]. The modulation of VEGF expression levels, in consequence of 
miR-369-3p regulation, could promote endothelial cell growth and neo-angiogenesis, 
which is a pivotal process in reproductive function regulating endometrial regeneration, 
corpus luteum formation, embryogenesis and placentation [82, 83].  
Thus, higher expression levels of this miRNA lead to a greater VEGF protein 
inhibition, affecting endometrial regeneration and the formation of the corpus luteum. If 
there is no regeneration of the endometrium walls, the shedding of the functional layer 
during menstruation can’t ensue. Besides, since the corpus luteum is involved in the 
production of relatively high levels of progesterone and moderate levels of estradiol, if its 
formation is compromised, so are the levels of these hormones. These abnormal (and 
low) levels of progesterone and estradiol will lead to the higher levels of LH and FSH, so 
characteristic of menopause. 
When the levels of progesterone and estradiol are very low, like is the case in 
menopause, VEGF is inhibited by miR-369-3p; therefore, we hypothesize this is the 
reason miR-369-3p levels are higher in older women. Furthermore, considering that the 
regeneration and growth of the human endometrium depends on an adequate angiogenic 
response, once a woman enters menopause, there isn’t a need for this response and, 
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theoretically, the levels of VEGF should decrease. Figure 7, displays the possible 
connection between VEGF and miR-369-3p and their role in the uterine cycle. The results 
of a study by Agrawal and colleagues, in which serum VEGF concentrations in the normal 
menstrual cycle were measured, corroborates our hypothesis [84]. 
 
 
 
Figure 7 – Potential role of miR-369-3p and VEGF in the uterine cycle. VEGF: vascular endothelial 
growth factor. (Adapted from http://www.utahfertility.com/infertility-diagnosis-treatment/fertiliy-your-
health/phases-of-menstrual-cycle-utah-county/ [85]). 
 
The difference in expression levels, some miRNAs show in body fluids (like miR-
369-3p in urine), detected throughout gender and different age groups, could be useful in 
forensic investigations, as it can help determine an age range or even the gender of the 
fluid’s donor. 
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6. Conclusion and Future Perspectives 
 
 
Throughout a crime scene investigation, traces of blood and urine are often found, 
especially in the form of dried stains that might not always contain enough DNA to obtain 
a DNA profile. In recent years, miRNA analysis has been described as having the 
potential to help identifying these fluids, mostly due to their intrinsically short size and 
tissue-specific expression. Nevertheless, even though over 1800 mature miRNAs have 
been identified in the human genome, it remains necessary to search for suitable miRNA 
markers for forensically relevant body fluids, like plasma and urine. Using blood and 
urinary miRNA biomarkers is especially useful since sample collections are fairly non-
invasive, they can be collected in a relatively large amount, urine especially, and multiple 
time-series measurements are easy to obtain. 
The present study highlights the importance of miR-369-3p as a potential forensic 
biomarker, as miR-369-3p showed higher expression levels in samples from older 
individuals (≥ 48 years). Taking into account our results, we hypothesize miR-369-3p and 
its influence on UQCRFS1 may be associated with age. It would be interesting to perform 
new studies evaluating the expression levels of miR-369-3p and its relation with 
UQCRFS1, in healthy individuals of different ages. As we only detected miR-369-3p in the 
urine of two male samples, we suggest that the difference in expression levels between 
age groups could be influenced by the high number of women included in this study. For 
this reason, we also hypothesize that miR-369-3p could be associated to the hormonal 
changes that occur during menopause. We propose that carrying out a study evaluating 
the expression levels of miR-369-3p in pre and post-menopausal women could help 
validate this miRNA as a urinary age biomarker for female samples.  
The difference in expression levels that miR-369-3p showed, in the age groups 
assessed, can be extremely valuable in forensic research, as it can help to establish the 
age range for the fluid’s donor. To the best of our knowledge, several studies trying to 
determine an association between miR-369-3p and age are performed using animal 
models or unhealthy individuals; thus, it would be interesting to carry out further studies, 
using a higher number of healthy individuals, to replicate the association.  
To our knowledge, this was the first study to identify miR-801 in urine samples and 
miR-323b-5p in plasma, which denotes a need for additional miRNA studies in the field of 
forensic sciences, and also emphasizes the importance of using a high number of 
samples. Hence, we also suggest this study to be replicated using a higher number of 
samples. Moreover, it would be interesting to test different pH levels in urine samples to 
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see what repercussions it has in the miRNAs expression levels. Additional research 
should also be dedicated towards the discovery of optimum miRNAs for body fluid 
identification and analysis of potential influences of environmental factors such as 
humidity, UV radiation and bacterial contamination on miRNA stability in vitro. 
MiRNAs are extremely resistant to temperature variations, so it would also be 
interesting to test if extracting and analyzing miRNAs in burn victims, when other 
forensically relevant molecules are degraded, could be viable.  
MiRNA analysis could, one day, become the gold standard of body fluid 
identification, and it might even follow the footsteps DNA profiling techniques took in the 
1980s, which could ultimately lead jurisdictions to accept expert testimony regarding 
miRNA matches between suspects and crime scene evidences.  
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Abstract 
Urine is perhaps the most amenable body fluid to perform routine testing, as it can be 
collected frequently and through non-invasive methods. Recently, in forensic science, 
microRNA profiling has been explored as an alternate method for body fluid identification. 
MicroRNAs also attracted great interest in forensic toxicology, since exposure to toxic 
compounds alters microRNA expression, which is then easily detected in urine. 
With this review, we intend to gather information about microRNAs that might have a 
urinary tract origin and could be potential biomarkers for urine identification. We also 
highlight the importance of establishing a connection between urinary microRNA 
expression and illicit substances, ultimately leading to a new drug evaluation method, 
representing a major breakthrough in the forensic field. 
 
 
